GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » EV-to-FCF

CurveBeam AI (ASX:CVB) EV-to-FCF : -3.17 (As of Mar. 29, 2025)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, CurveBeam AI's Enterprise Value is A$54.15 Mil. CurveBeam AI's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-17.10 Mil. Therefore, CurveBeam AI's EV-to-FCF for today is -3.17.

The historical rank and industry rank for CurveBeam AI's EV-to-FCF or its related term are showing as below:

ASX:CVB' s EV-to-FCF Range Over the Past 10 Years
Min: -3.57   Med: -1.52   Max: -0.84
Current: -3.17

During the past 4 years, the highest EV-to-FCF of CurveBeam AI was -0.84. The lowest was -3.57. And the median was -1.52.

ASX:CVB's EV-to-FCF is ranked worse than
100% of 380 companies
in the Medical Devices & Instruments industry
Industry Median: 27.14 vs ASX:CVB: -3.17

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-29), CurveBeam AI's stock price is A$0.12. CurveBeam AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.053. Therefore, CurveBeam AI's PE Ratio (TTM) for today is At Loss.


CurveBeam AI EV-to-FCF Historical Data

The historical data trend for CurveBeam AI's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI EV-to-FCF Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24
EV-to-FCF
- - - -2.72

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial - - - -2.72 -

Competitive Comparison of CurveBeam AI's EV-to-FCF

For the Medical Devices subindustry, CurveBeam AI's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CurveBeam AI's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's EV-to-FCF falls into.


;
;

CurveBeam AI EV-to-FCF Calculation

CurveBeam AI's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=54.148/-17.095
=-3.17

CurveBeam AI's current Enterprise Value is A$54.15 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CurveBeam AI's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was A$-17.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CurveBeam AI  (ASX:CVB) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

CurveBeam AI's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.12/-0.053
=At Loss

CurveBeam AI's share price for today is A$0.12.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CurveBeam AI's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.053.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


CurveBeam AI EV-to-FCF Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.

CurveBeam AI Headlines

No Headlines